Om Prakash Singh Patel

Dr. Om Prakash Singh Patel

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
OPOm Prakash Singh Patel
Om Prakash Singh Patel
RBRichard M. Beteck
Richard M. Beteck
LLLesetja J. Legoabe
Lesetja J. Legoabe

3 May 2016 in Journal of Natural Products
Verified
Journal Article
Closed access
OPOm Prakash Singh Patel
Om Prakash Singh Patel
AMAkansha Mishra
Akansha Mishra
RMRanjani Maurya
Ranjani Maurya
DSDeepika Saini
Deepika Saini
JPJyotsana Pandey
Jyotsana Pandey
PYPrem P. Yadav
Prem P. Yadav

20 January 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DADevireddy Anand
Devireddy Anand
PYPawan Kumar Yadav
Pawan Kumar Yadav
OPOm Prakash Singh Patel
Om Prakash Singh Patel
NPNaveen Parmar
Naveen Parmar
RMRahul Maurya
Rahul Maurya
PYPrem P. Yadav
Prem P. Yadav

12 August 2016 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
OPOm Prakash Singh Patel
Om Prakash Singh Patel
DADevireddy Anand
Devireddy Anand
RMRahul Maurya
Rahul Maurya
PYPrem Prakash Yadav
Prem Prakash Yadav

30 November 2018 in ACS Omega
Verified
Journal Article
Open access
NNNitesh Kumar Nandwana
Nitesh Kumar Nandwana
OPOm Prakash Singh Patel
Om Prakash Singh Patel
OPOm P. S. Patel
Om P. S. Patel
SDShiv Dhiman
Shiv Dhiman
HSHitesh Kumar Saini
Hitesh Kumar Saini
AKAnil Kumar
Anil Kumar
A new class of fused quinazolines has been designed and synthesized via copper-catalyzed Ullmann type C–N coupling followed by intramolecular cross-dehydrogenative coupling reaction in moderate to good yields. The synthesized compounds were tested for in vitro antibacterial activity against three Gram negative (Escherichia coli, Pseudomonas putida, and Salmonella typhi) and two Gram positive (Bacillus subtilis, and Staphylococcus aureus) bacteria. Among all tested compounds, 8ga, 8gc, and 8gd exhibited promising minimum inhibitory concentration (MIC) values (4–8 μg/mL) for all bacterial strains tested as compared to the positive control ciprofloxacin. The synthesized compounds were also evaluated for their in vitro antifungal activity against Aspergillus niger and Candida albicans and compounds 8ga, 8gc, and 8gd having potential antibacterial activity also showed pronounced antifungal activity (MIC values 8–16 μg/mL) against both strains. The bactericidal assay by propidium iodide and live–dead bacterial cell screening using a mixture of acridine orange/ethidium bromide (AO/Et·Br) showed considerable changes in the bacterial cell membrane, which might be the cause or consequence of cell death. Moreover, the hemolytic activity for most potent compounds (8ga, 8gc, and 8gd) showed their safety profile toward human blood cells.

8 May 2015 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
OPOm Prakash Singh Patel
Om Prakash Singh Patel
DADevireddy Anand
Devireddy Anand
RMRahul Maurya
Rahul Maurya
PYPrem P. Yadav
Prem P. Yadav
An environmentally benign protocol for the synthesis of N-(pyridine-2-yl)amides from aldehydes and 2-aminopyridines has been developed under mild conditions.